\-\ Texto\\:\\ \ \(0\)\
\-\ fever\\.\\ \\ no\\ focal\\ deficit\\.\ \(0\)\
\-\ antibiotics\\ with\\ almost\\ full\\ resolution\\ of\\ lesions\\ after\\ two\\ months\\.\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ ring\\ enhancing\\ lesions\\ involving\\ both\\ cerebral\\ hemispheres\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ most\\ of\\ the\\ lesion\\ also\\ have\\ restricted\\ diffusion\\.\ \(0\)\
\-\ brain\\ abscess\\ \\(gram\\ positive\\ cocci\\)\\ with\\ streptococcus\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ bacterial\\ abscess\ \(0\)\
\-\ \\â\\€\\¢\\ toxoplasmosis\ \(0\)\
\-\ \\â\\€\\¢\\ multifocal\\ gbm\ \(0\)\
\-\ 21\\ year\\ old\\ adult\\ with\\ down\\ syndrome\\,\\ was\\ treated\\ for\\ otitis\\ media\\ 1\\ week\\ prior\\ to\\ admission\\.\\ \\ he\\ developed\\ severe\\ headache\\ and\\ fever\\ on\\ the\\ day\\ of\\ admission\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.10684188760881053\ \(0\)\
\-\ admission\\:\\ 0\\.0855832367435673\ \(0\)\
\-\ cocci\\:\\ 0\\.0719387701611193\ \(0\)\
\-\ fever\\:\\ 0\\.06571051423981741\ \(0\)\
\-\ streptococcus\\:\\ 0\\.0650508633023657\ \(0\)\
\-\ otitis\\:\\ 0\\.06359821135338975\ \(0\)\
\-\ toxoplasmosis\\:\\ 0\\.06231038538399198\ \(0\)\
\-\ media\\:\\ 0\\.06191162038613664\ \(0\)\
\-\ abscess\\:\\ 0\\.06140536918486971\ \(0\)\
\-\ gram\\:\\ 0\\.06010406703807201\ \(0\)\
\-\ gbm\\:\\ 0\\.05743543532128336\ \(0\)\
\-\ multifocal\\:\\ 0\\.05222739453170899\ \(0\)\
\-\ lesions\\:\\ 0\\.05199001150781699\ \(0\)\
\-\ hemispheres\\:\\ 0\\.05173680166960435\ \(0\)\
\-\ deficit\\:\\ 0\\.050099990644343693\ \(0\)\
\-\ bacterial\\:\\ 0\\.04969167235768388\ \(0\)\
\-\ adult\\:\\ 0\\.048669533304695936\ \(0\)\
\-\ almost\\:\\ 0\\.046970309055025895\ \(0\)\
\-\ ring\\:\\ 0\\.045128765198953494\ \(0\)\
\-\ restricted\\:\\ 0\\.044689960242955996\ \(0\)\
\-\ 21\\:\\ 0\\.04394043788168557\ \(0\)\
\-\ diffusion\\:\\ 0\\.0434668845134973\ \(0\)\
\-\ full\\:\\ 0\\.04194948232458227\ \(0\)\
\-\ resolution\\:\\ 0\\.041882042148220736\ \(0\)\
\-\ down\\:\\ 0\\.04168209030855733\ \(0\)\
\-\ developed\\:\\ 0\\.037387107782212665\ \(0\)\
\-\ antibiotics\\:\\ 0\\.03647404951898297\ \(0\)\
\-\ involving\\:\\ 0\\.034072809818219245\ \(0\)\
\-\ cerebral\\:\\ 0\\.03364143752004626\ \(0\)\
\-\ headache\\:\\ 0\\.03335210724506589\ \(0\)\
\-\ week\\:\\ 0\\.03297744793554805\ \(0\)\
\-\ positive\\:\\ 0\\.031510063525955874\ \(0\)\
\-\ day\\:\\ 0\\.030829088969919656\ \(0\)\
\-\ enhancing\\:\\ 0\\.030454017419144993\ \(0\)\
\-\ severe\\:\\ 0\\.029878520455295505\ \(0\)\
\-\ brain\\:\\ 0\\.02921990367389502\ \(0\)\
\-\ treated\\:\\ 0\\.02906648677368022\ \(0\)\
\-\ two\\:\\ 0\\.027810582245636428\ \(0\)\
\-\ syndrome\\:\\ 0\\.027771665644711837\ \(0\)\
\-\ focal\\:\\ 0\\.027732881865209114\ \(0\)\
\-\ he\\:\\ 0\\.02709303797764795\ \(0\)\
\-\ months\\:\\ 0\\.026522060166932582\ \(0\)\
\-\ prior\\:\\ 0\\.024933099684117766\ \(0\)\
\-\ both\\:\\ 0\\.024797727166887742\ \(0\)\
\-\ metastatic\\:\\ 0\\.024444425041091934\ \(0\)\
\-\ 1\\:\\ 0\\.023105981454087578\ \(0\)\
\-\ most\\:\\ 0\\.022418581156000865\ \(0\)\
\-\ have\\:\\ 0\\.021027705435966954\ \(0\)\
\-\ multiple\\:\\ 0\\.020452340948628057\ \(0\)\
\-\ after\\:\\ 0\\.020090922756922754\ \(0\)\
\-\ lesion\\:\\ 0\\.019779036659096076\ \(0\)\
\-\ also\\:\\ 0\\.019143404473524448\ \(0\)\
\-\ disease\\:\\ 0\\.01587201751381482\ \(0\)\
\-\ was\\:\\ 0\\.011230426388791896\ \(0\)\
\-\ year\\:\\ 0\\.010864832605374032\ \(0\)\
\-\ old\\:\\ 0\\.009942438600707438\ \(0\)\
\-\ no\\:\\ 0\\.009777774439815931\ \(0\)\
\-\ for\\:\\ 0\\.008285319870939944\ \(0\)\
\-\ on\\:\\ 0\\.00822603423142532\ \(0\)\
\-\ \\(\\:\\ 0\\.00820865598004387\ \(0\)\
\-\ \\)\\:\\ 0\\.008108382864923921\ \(0\)\
\-\ to\\:\\ 0\\.004853046686852117\ \(0\)\
\-\ with\\:\\ 0\\.003988778730337149\ \(0\)\
\-\ of\\:\\ 0\\.003971720481749605\ \(0\)\
\-\ the\\:\\ 0\\.0031420291978096772\ \(0\)\
\-\ \\,\\:\\ 0\\.003076250744514629\ \(0\)\
\-\ \\.\\:\\ 0\\.002823826735016181\ \(0\)\
\-\ and\\:\\ 0\\.0020455568833206645\ \(0\)\
